Brief: China Biotech Services Posts Qtrly Loss For Period HK$55 Mln
13/11/2023 10:40
China Biotech Services Holdings Ltd 8037.HK
* QTRLY LOSS FOR PERIOD HK$55 MLN VS PROFIT HK$257.2 MLN
* QTRLY TURNOVER HK$18.4 MLN VS HK$588.8 MLN
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)